You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CRPC; POL

Showing 1 - 25 of 230
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Castration-resistant Prostate Cancer Trial in Wuxi (Polaprezinc, Abiraterone)

Enrolling by invitation
  • Castration-resistant Prostate Cancer
  • Wuxi, Jiangsu, China
    Jiangnan University
Sep 18, 2022

Prostatic Tumors, Exercise, Castration-resistant Prostate Cancer Trial in Ghent (Exercise)

Completed
  • Prostatic Neoplasms
  • +3 more
  • Exercise
  • Ghent, Oost-Vlaanderen, Belgium
    University Hospital ghent
Dec 22, 2022

Rheumatic Diseases, COVID-19 Vaccine, COVID-19 Trial in Chicago (COVID-19 vaccine and booster training, and importance)

Not yet recruiting
  • Rheumatic Diseases
  • +3 more
  • COVID-19 vaccine and booster training, and importance
  • Chicago, Illinois
    Northwestern University
Apr 7, 2023

Multicenter Study of Polish Patients With HF and LVEF >40%

Active, not recruiting
  • Heart Failure
    • Łódź, Poland
      Department of Noninvasive Cardiology, Medical University of Lodz
    Sep 7, 2023

    HIV-1-infection Trial in Los Angeles, San Francisco (PENNVAX-GP, INO-6145, INO-9012)

    Completed
    • HIV-1-infection
    • PENNVAX-GP
    • +3 more
    • Los Angeles, California
    • +1 more
    Apr 4, 2022

    Metastatic Castration-resistant Prostate Cancer Trial in Korea, Republic of, United States (Phase I and Phase II:

    Recruiting
    • Metastatic Castration-resistant Prostate Cancer
    • Phase I and Phase II: LAE001/prednisone + afuresertib
    • Tucson, Arizona
    • +16 more
    Nov 30, 2022

    Castration-Resistant Prostate Cancer Trial (SHR3680 tablets)

    Not yet recruiting
    • Castration-Resistant Prostate Cancer
    • SHR3680 tablets
    • (no location specified)
    Nov 1, 2022

    Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL), Castration Resistant Prostate Cancer (CRPC) Trial in Russian

    Recruiting
    • Small Cell Lung Cancer (SCLC)
    • +2 more
    • Tucson, Arizona
    • +62 more
    Jan 18, 2023

    Castrate-Resistant Prostate Cancer Trial in Shanghai (LIGHT-PSMA-CART cells)

    Suspended
    • Castrate-Resistant Prostate Cancer
    • LIGHT-PSMA-CART cells
    • Shanghai, Shanghai, China
      Changhai Hospital
    Jan 25, 2023

    Coronary Artery Aneurysm, Coronary Artery Ectasia Trial in Poznan

    Recruiting
    • Coronary Artery Aneurysm
    • Coronary Artery Ectasia
      • Poznań, Wielkopolska, Poland
        Poznan University of Medical Sciences, Poland
      Sep 27, 2023

      Castration Resistant Prostate Cancer Trial run by the National Cancer Institute (NCI) (Bintrafusp alfa, N-803, BN-Brachyury)

      Not yet recruiting
      • Castration Resistant Prostate Cancer
      • Bintrafusp alfa
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Feb 2, 2023

      Castration-Resistant Prostate Cancer Trial in Worldwide (Apalutamide)

      Active, not recruiting
      • Castration-Resistant Prostate Cancer
      • Greenville, South Carolina
      • +4 more
      Aug 2, 2022

      Castration-resistant Prostate Cancer, Metastatic Cancer Trial (Cabozantinib, Nivolumab)

      Not yet recruiting
      • Castration-resistant Prostate Cancer
      • Metastatic Cancer
      • (no location specified)
      Aug 12, 2022

      Prostatic Tumors Trial in Brazil, Colombia, Mexico (Apalutamide, ADT (Standard of Care))

      Available
      • Prostatic Neoplasms
      • Florianopolis, Brazil
      • +19 more
      Aug 2, 2022

      Prostate Cancer Trial in Rochester (Cisplatin)

      Recruiting
      • Prostate Cancer
      • Rochester, New York
        Wilmot Cancer Institute
      Jun 7, 2022

      Melanoma Trial in Canada, United States (POL-103A, POL-103A without API)

      Terminated
      • Melanoma
      • POL-103A
      • POL-103A without API
      • Chandler, Arizona
      • +64 more
      Dec 6, 2021

      Treatment Satisfaction With Ra-223 in Japan

      Active, not recruiting
      • Prostatic Neoplasms
      • Radium-223 dichloride (Xofigo, BAY88-8223)
      • Multiple Locations, Japan
        Many Locations
      Jan 12, 2023

      Castration Resistant Prostate Cancer, Castration Sensitive Prostate Cancer Trial in Portland (drug, procedure, other)

      Not yet recruiting
      • Castration Resistant Prostate Cancer
      • Castration Sensitive Prostate Cancer
      • Portland, Oregon
        OHSU Knight Cancer Institute
      Jun 16, 2023

      Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or

      Completed
      • Avelumab in Combination With Talazoparib Will be Investigated in Patients With Locally Advanced (Primary or Recurrent) or Metastatic Solid Tumors
      • Avelumab Phase 1b
      • +3 more
      • Fayetteville, Arkansas
      • +57 more
      Jan 18, 2023

      Prostate Cancer Trial in Kogarah, Liverpool, Bedford Park (PCUR-101, Dutasteride 0.5 mg, Abiraterone and Prednisone)

      Recruiting
      • Prostate Cancer
      • Ann Arbor, Michigan
      • +4 more
      Jan 6, 2023

      Fasting, Prostatic Tumors Trial in Berlin (Fasting, Control)

      Completed
      • Fasting
      • Prostatic Neoplasms
      • Fasting
      • Control
      • Berlin, Germany
        Charité Centrum Chirurgische Medizin, CC 8 Klinik für Urologie
      Dec 12, 2022

      Prostatic Tumors Trial in China (Apalutamide, Placebo, Androgen-deprivation Therapy (ADT))

      Recruiting
      • Prostatic Neoplasms
      • Beijing, China
      • +29 more
      Aug 15, 2022

      Advanced Solid Malignancies Trial in United Kingdom, United States (CT7001, CT7001 in combination with fulvestrant, CT7001 (in

      Completed
      • Advanced Solid Malignancies
      • CT7001
      • CT7001 in combination with fulvestrant
      • Tucson, Arizona
      • +22 more
      Jan 26, 2023

      Castration Resistant Metastatic Prostate Cancer Trial in Baltimore (Testosterone cypionate, Enzalutamide, Testosterone

      Recruiting
      • Castration Resistant Metastatic Prostate Cancer
      • Testosterone cypionate
      • +2 more
      • Baltimore, Maryland
        Johns Hopkins University/Sidney Kimmel Cancer Center
      Aug 4, 2022

      HIV Trial in American Samoa, Australia, United States (MRKAd5 HIV-1 gag/pol/nef, MRKAd5 HIV-1 gag/pol/nef )

      Completed
      • HIV Infections
      • MRKAd5 HIV-1 gag/pol/nef
      • MRKAd5 HIV-1 gag/pol/nef placebo
      • San Diego, California
      • +22 more
      Oct 28, 2021